Michael Hochman, MD

Background

A board certified hematologist, Dr. Hochman treats patients with acute leukemia, myelodysplastic neoplasms and other myeloid malignancies.

Dr. Hochman is a member of the Discovery and Developmental Therapeutics Research Program at Winship Cancer Institute of Emory University.

Dr. Hochman received his Medical Degree from Duke University School of Medicine in Durham, North Carolina. He completed his residency at University of Washington Affiliated Hospitals in Seattle, Washington. He completed his fellowship in hematology at Johns Hopkins University School of Medicine in Baltimore, Maryland, where he served as Chief Fellow in his final year.

Dr. Hochman's research focuses on developing novel therapeutic strategies for treatment of myeloid malignancies, including new drugs and drug combinations. He is also studying the use of new technologies to better predict treatment outcomes and assess measurable residual disease among clonal myeloid disorders.

Dr. Hochman received the ASH Abstract Achievement Award for his work on ontogeny and genetics in acute myeloid leukemia, presented at the 2022 American Society of Hematology Annual Meeting.

Titles & Roles

• Assistant Professor, Department of Hematology and Medical Oncology

  Emory University School of Medicine

Education & Training

Education

• Fellowship, Hematology/Oncology, 2023

  Johns Hopkins University School of Medicine
• Internship, Internal Medicine, 2020

  University of Washington School of Medicine
• Medical Education, , 2017

  Duke University School of Medicine

Board Certifications

• Hematology

  American Board of Internal Medicine, 2022
• Internal Medicine

  American Board of Internal Medicine, 2020

Professional Memberships

• American Society of Hematology
• American Society of Clinical Oncology
• Society of Hematologic Oncology.

Ratings & Reviews

Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.